ASRC Press Releases

NAD Recommends Pursuit of Research Discontinue All Challenged Claims for Supplement Marketed as ‘Cures’ for Brain Injury, ADHD, Autism

NAD has recommended that Pursuit of Research, LLC, discontinue all challenged claims for the company’s Nutriiveda dietary supplements, which are marketed as “cures” for conditions that include attention deficit disorder, apraxia, autism, diabetes, dyspraxia, seizures, traumatic brain injury and stroke. The advertiser said it will appeal NAD’s decision to NARB.

Read More

ASRC President Testifies on Weight-Loss Products Before Senate Commerce Subcommittee

Lee Peeler, President and CEO, testified Tuesday, June 17, before a U.S. Senate subcommittee hearing on "Protecting Consumers from False and Deceptive Advertising of Weight-Loss Products."

Read More

NARB Panel Recommends Zero Technologies Discontinue Broadcast Ad Challenged by Clorox, Finds Advertiser Can Support Filter Claim made for ZeroWater Pitcher

A five-member panel of NARB has recommended that Zero Technologies, the maker of the ZeroWater Z-Pitcher, discontinue a broadcast advertisement that implies a competing product is not effective at filtering contaminants from drinking water.

Read More

NAD Finds Westport Can Support Claims for ZEPHREX-D Following Challenge by Acura Pharmaceuticals

NAD has determined that Westport Pharmaceuticals, LLC, maker of ZEPHREX-D nasal decongestant tablets, can support the claims challenged before NAD by Acura Pharmaceuticals, Inc., the maker of NEXAFED, a competing product.

Read More

NAD Determines Aggregated Online Reviews Don’t Support Claims that Euro-Pro’s Shark Vacuums Are ‘America’s Most Recommended,’ Euro-Pro to Appeal

NAD, in a case of first impression, determined that survey information culled from multiple online venues was insufficiently reliable and representative to support a broad “America’s Most Recommended” claim.

Read More

NAD Recommends iSatori Discontinue Certain Claims for ‘Energize’ Supplement, Finds Company Can Support Certain Claims

NAD has recommended that iSatori, Inc., discontinue certain claims for the company’s Energize dietary supplement, including claims of “8-Hour Efficacy Shown in Clinical Testing.” NAD determined, however, that the advertiser could support certain claims.

Read More